BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab
Elisabetta Signoriello, Simona Bonavita, Andrea Di Pietro, Gianmarco Abbadessa, F. Rossi, Giuseppina Miele, Sara Casertano, Giacomo Lus
Topics & Concepts
OcrelizumabMedicineMultiple sclerosisDermatologyInternal medicineImmunologyRituximabLymphomaMultiple Sclerosis Research StudiesDiabetes and associated disordersSystemic Sclerosis and Related Diseases